Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen Idec quietly carves out a leading role in developing gene therapy for hemophilia
Biogen Idec quietly carves out a leading role in developing gene therapy for hemophilia
Biogen Idec quietly carves out a leading role in developing gene therapy for hemophilia
Submitted by
admin
on January 29, 2015 - 9:41am
Source:
Fierce Biotech
News Tags:
Biogen Idec
hemophilia B
hemophilia A
hemophilia
gene therapy
Headline:
Biogen Idec quietly carves out a leading role in developing gene therapy for hemophilia
Do Not Allow Advertisers to Use My Personal information
